Entries by Rebecca Mercer

Recruiting: Expert Advisor, OncoSim Technical Working Group

View full posting details on the CPAC website here Reports to:       Director, Performance Location:          Downtown Toronto (work from home until the expected return to the office in 2022) Employment category:  Consultant Closing Date:   September 17, 2021 The Partnership is seeking an exceptional individual to fill the position of an Expert Advisor (more…)

*New* Patient Involvement in Cancer Research Program (PIP) Small Research Grant Competition

As part of its commitment to patient engagement in cancer research, the Canadian Cancer Research Alliance (CCRA) is releasing its inaugural funding opportunity as part of its Patient Involvement in Cancer Research Program (PIP). Integrated with the biennial Canadian Cancer Research Conference (CCRC) since 2017, PIP provides patient partners with (more…)

Vice-President, Cancer Control (Canadian Partnership Against Cancer)

Closing Date: September 1, 2021 Overview: This is an exciting opportunity for an inspiring, agile, strategic, empathic, and empowering leader to join the Canadian Partnership Against Cancer as its next Vice President, Cancer Control. The Canadian Partnership Against Cancer (the Partnership) works with Canada’s healthcare and cancer care community as well as (more…)

PMPRB Stakeholder Consultation

The Patented Medicine Prices Review Board (PMPRB) invites stakeholders to comment on three proposed amendments to the new PMPRB Guidelines related to the decision to delay the coming-into-force date of the Regulations Amending the Patented Medicines Regulations (“Regulations”) a further six months, from July 1, 2021 to January 1, 2022.  (more…)

Sr. Manager – Cancer Prevention (Quebec)

The Canadian Cancer Society is seeking a Quebec-based Senior Manager – Cancer Prevention. To apply, see details below. La version française suit. Permanent – Full-time Location:  Montreal or anywhere in Quebec JOB OVERVIEW The Senior Manager is responsible for the Canadian Cancer Society’s cancer prevention and health promotion program for the (more…)

New Publication: Real-World Cost-Effectiveness of Bevacizumab With First-Line Combination Chemotherapy in Patients With Metastatic Colorectal Cancer: Population-Based Retrospective Cohort Studies in Three Canadian Provinces

We are excited to share this three-province cost-effectiveness analysis of bevacizumab with first line combination chemotherapy in patients with metastatic colorectal cancer. View the full text at https://journals.sagepub.com/doi/full/10.1177/23814683211021060 Download a PDF copy by Clicking Here Authors: Reka E. Pataky , Jaclyn Beca , David Tran, Wei Fang Dai, Erind Dvorani, (more…)